Timothy Rolph, DPhil

2020

In 2020, Timothy Rolph, DPhil earned a total compensation of $2M as Chief Scientific Officer at Akero Therapeutics.

Compensation breakdown

Bonus$207,000
Option Awards$1,379,768
Salary$414,000
Total$2,000,768

DPhil received $1.4M in option awards, accounting for 69% of the total pay in 2020.

DPhil also received $207K in bonus and $414K in salary.

Rankings

In 2020, Timothy Rolph, DPhil's compensation ranked 5,514th out of 13,090 executives tracked by ExecPay. In other words, DPhil earned more than 57.9% of executives.

ClassificationRankingPercentile
All
5,514
out of 13,090
58th
Division
Manufacturing
2,268
out of 5,618
60th
Major group
Chemicals And Allied Products
908
out of 2,251
60th
Industry group
Drugs
785
out of 1,951
60th
Industry
Pharmaceutical Preparations
584
out of 1,456
60th
Source: SEC filing on April 28, 2023.

DPhil's colleagues

We found three more compensation records of executives who worked with Timothy Rolph, DPhil at Akero Therapeutics in 2020.

2020

Andrew Cheng

Akero Therapeutics

Chief Executive Officer

2020

Jonathan Young

Akero Therapeutics

Chief Operating Officer

2020

William White

Akero Therapeutics

Chief Financial Officer

News

In-depth

You may also like